STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
414
13F, latest reported quarter
What the filings say about BG
Insiders, 180 days
+$689.0K net bought
1 buyer
Bunge Global insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Bunge Global SA insiders bought a net $689.0K of stock across 65 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Aug 18, 2025.
The trade is 37.5% of the 13,320 shares held after it.
No other insider bought within 30 days.
414 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Mahoney Christopher bought about $527.6K of BG on Jul 31, 2026, the largest insider purchase at the company on our record; 414 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on May 22, 2024.
The trade is 4.3% of the 124,536 shares held after it.
No other insider sold within 30 days.
414 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive VP, Global Markets Dimopoulos Christos sold about $500.2K of BG on Nov 21, 2025, the largest insider sale at the company since 2024; 414 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on May 22, 2024.
The trade is 19.1% of the 104,536 shares held after it.
No other insider sold within 30 days.
414 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive VP, Global Markets Dimopoulos Christos sold about $1.9M of BG on Nov 21, 2025, the largest insider sale at the company since 2024; 414 funds added in the latest 13F quarter.
65 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BG planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
BG mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Shelton Sustainable Equity Fund
$3.5M position · as of 2026-05-31
4.9%
iShares MSCI Agriculture Producers ETF
$4.9M position · as of 2026-05-31
3.1%
Catalyst/MAP Global Equity Fund
$2.5M position · as of 2026-06-30
2.6%
Invesco S&P 500 Equal Weight Consumer Staples ETF
$6.2M position · as of 2026-07-31
2.5%
Invesco Food & Beverage ETF
$2.6M position · as of 2026-07-31
2.4%
Catalyst/MAP Global Balanced Fund
$343.4K position · as of 2026-06-30
2.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$18.9M
$24.5M
$7.7M
+55%
+1%
2024
$16.8M
$1.9M
$4.6M
+31%
+8%
2023
$17.6M
$18.4M
$4.7M
+65%
+18%
2022
$17.9M
$36.9M
$5.0M
+59%
+30%
2021
$16.1M
$53.4M
$6.5M
+46%
+15%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $689.0K bought by insiders over 180 days, 414 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$80.5B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM BG
FY Mar 2026
$80.5B
FY Dec 2025
$70.3B
FY Mar 2025
$51.3B
FY Dec 2024
$53.1B
FY Dec 2023
$59.5B
Mar 2026
$21.9B
Dec 2025
$23.8B
Sep 2025
$22.2B
Jun 2025
$12.8B
Mar 2025
$11.6B
Dec 2024
$13.5B
Sep 2024
$12.9B
Jun 2024
$13.2B
At each fiscal year end
Single quarter
Net margin, TTM
+0.8%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM BG
FY Mar 2026
+0.8%
FY Dec 2025
+1.2%
FY Mar 2025
+2.1%
FY Dec 2024
+2.1%
FY Dec 2023
+3.8%
Mar 2026
+0.3%
Dec 2025
+0.4%
Sep 2025
+0.7%
Jun 2025
+2.8%
Mar 2025
+1.7%
Dec 2024
+4.4%
Sep 2024
+1.7%
Jun 2024
+0.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$1.2B
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM BG
FY Mar 2026
-$1.2B
FY Dec 2025
-$879.0M
FY Mar 2025
-$829.0M
FY Dec 2024
$524.0M
FY Dec 2023
$2.2B
Mar 2026
-$877.0M
Dec 2025
$809.0M
Sep 2025
$385.0M
Jun 2025
-$1.5B
Mar 2025
-$595.0M
Dec 2024
$564.0M
Sep 2024
$973.0M
Jun 2024
-$1.8B
At each fiscal year end
Single quarter
Debt to equity
0.91x
long-term 2026-03-31 plus current 2026-03-31; equity 2026-03-31
Debt to equity BG
FY Mar 2026
0.91x
FY Dec 2025
0.88x
FY Mar 2025
0.63x
FY Dec 2024
0.63x
FY Dec 2023
0.45x
Mar 2026
0.91x
Dec 2025
0.88x
Sep 2025
0.99x
Jun 2025
1.04x
Mar 2025
0.63x
Dec 2024
0.63x
Sep 2024
0.61x
Jun 2024
0.50x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.04x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-03-31
Cash flow to debt BG
FY Mar 2026
0.04x
FY Dec 2025
0.06x
FY Mar 2025
0.09x
FY Dec 2024
0.30x
FY Dec 2023
0.68x
Mar 2026
0.04x
Dec 2025
0.06x
Sep 2025
0.04x
Jun 2025
0.09x
Mar 2025
0.09x
Dec 2024
0.30x
Sep 2024
0.37x
Jun 2024
0.47x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.1%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity BG
FY Mar 2026
+5.1%
FY Dec 2025
+6.3%
FY Mar 2025
+10.4%
FY Dec 2024
+11.0%
FY Dec 2023
+22.3%
Mar 2026
+5.1%
Dec 2025
+6.3%
Sep 2025
+10.2%
Jun 2025
+13.2%
Mar 2025
+10.4%
Dec 2024
+11.0%
Sep 2024
+10.8%
Jun 2024
+12.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.8%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets BG
FY Mar 2026
+1.8%
FY Dec 2025
+2.4%
FY Mar 2025
+4.2%
FY Dec 2024
+4.5%
FY Dec 2023
+9.0%
Mar 2026
+1.8%
Dec 2025
+2.4%
Sep 2025
+3.7%
Jun 2025
+5.0%
Mar 2025
+4.2%
Dec 2024
+4.5%
Sep 2024
+4.6%
Jun 2024
+5.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital BG
FY Mar 2026
n/a
FY Dec 2025
n/a
FY Mar 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed BG
FY Mar 2026
n/a
FY Dec 2025
n/a
FY Mar 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
23.63x
close 2026-10-27 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing BG
FY Mar 2026
29.65x
FY Dec 2025
16.44x
FY Mar 2025
9.70x
FY Dec 2024
9.62x
FY Dec 2023
6.78x
Mar 2026
29.65x
Dec 2025
16.44x
Sep 2025
8.75x
Jun 2025
8.02x
Mar 2025
9.70x
Dec 2024
9.62x
Sep 2024
12.23x
Jun 2024
12.12x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$33.4B
market value at close 2026-10-27 on 2026-04-27 shares, plus long-term 2026-03-31 plus current 2026-03-31, minus cash 2026-03-31
Enterprise value BG
FY Mar 2026
$38.3B
FY Dec 2025
$30.1B
FY Mar 2025
$13.7B
FY Dec 2024
$13.8B
FY Dec 2023
n/a
Mar 2026
$38.3B
Dec 2025
$30.1B
Sep 2025
$30.5B
Jun 2025
$15.3B
Mar 2025
$13.7B
Dec 2024
$13.8B
Sep 2024
$17.0B
Jun 2024
$19.0B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-5.9%
TTM free cash flow over market value at close 2026-10-27
FCF yield BG
FY Mar 2026
-4.7%
FY Dec 2025
-5.1%
FY Mar 2025
-8.1%
FY Dec 2024
+4.8%
FY Dec 2023
n/a
Mar 2026
-4.7%
Dec 2025
-5.1%
Sep 2025
-6.9%
Jun 2025
-5.0%
Mar 2025
-8.1%
Dec 2024
+4.8%
Sep 2024
+8.0%
Jun 2024
+8.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -46%, PEG needs growth
PEG, trailing BG
FY Mar 2026
n/a
FY Dec 2025
n/a
FY Mar 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
0.16x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
0.50x
Jun 2025
0.59x
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BG ranks highest on institutional and government (85th percentile) and risk and compliance (79th), and lowest on financial health (34th), among Food & Beverage peers.
Profitability
51
Inputs
Return on equity+5.1% · 51 pct, sector of 66
Return on assets+1.8% · 51 pct, sector of 77
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
34
Inputs
Debt to equity0.91x · 34 pct, sector of 66
Cash flow to debt0.04x · 34 pct, sector of 59
Growth
68
Inputs
Revenue growth, YoY+9.0% · 68 pct, sector of 89
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
64
Inputs
Net Form 4 buying (codes P and S), 180d$689K · 87 pct, sector of 56
Insider buyers, 180d1 · 40 pct, sector of 56
Institutional and government
85
Inputs
Funds adding, latest quarter414 · 85 pct, sector of 79
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
79
Inputs
Short interest, % of float+4.9% · 46 pct, sector of 100
Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 58
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 58
New text in Risk Factors, latest 10-K+8.3% · 68 pct, sector of 66
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BG filings, in plain words
Are Bunge Global insiders buying or selling BG?
In the 180 days to 2026-10-28, Bunge Global insiders were net buyers, a net $689.0K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-28, Bunge Global insiders were net buyers of BG, a net $689.0K across purchases and sales reported on Form 4 by 1 buyer. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.